A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice

200159 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Cancer

Volume 37, Issue 1, pp. 106-113

Field-Weighted Citation Impact: 2.19